Failing to Identify Parent Company as Real Party-In-Interest Proves Fatal to Petition for IPR

Sep 10, 2018

Reading Time : 1 min

Whether a non-party should be listed as an RPI is a fact-dependent inquiry. Factors that the Board consider include “whether a non-party exercises control over a petitioner’s participation in the proceeding and whether the non-party is directing the proceeding.” 

The Patent Owner presented undisputed evidence that Petitioner is a wholly owned subsidiary of XM Holdings, nine executive officers of XM Holdings are the same as those of Petitioner, XM Holdings’ SEC filings indicate that it was a defendant in legal proceedings that name only Petitioner (including patent infringement cases), and XM Holdings funded a settlement in certain class-action lawsuits filed against Petitioner.   

The Board relied on this evidence and concluded that XM Holdings was an RPI. Although Petitioner argued—and submitted a declaration from its General Counsel attesting—that XM Holdings has not and will not actually control this proceeding, the Board rejected the argument explaining that actual control is not the only measure in the RPI analysis. The Board explained that the RPI inquiry includes a determination of whether there is an opportunity to control, taking into account “whether the non-party is a clear beneficiary that has a preexisting, established relationship with the petitioner.” Based on the evidence, the Board determined that XM Holdings has this relationship with Petitioner and should have been identified as an RPI.   

In the alternative, Petitioner had requested authorization to amend its petition to name XM Holdings so as to keep its original filing date if the Board determined that XM Holdings was an RPI. The Board, however, denied the request.

Practice Tip: Careful consideration should be given to disclosure, as real parties-in-interest, of entities with an established relationship to IPR petitioners, including parent companies, especially when there is even the slightest indicia of involvement in the IPR proceeding or related litigation.

Sirius XM Radio, Inc. v. Fraunhofer-Gesellschaft zur Forderung der angewandten Förschung e. V, IPR2018-00681 (PTAB Sept. 6, 2018).

Share This Insight

Previous Entries

IP Newsflash

July 22, 2026

The Court of Federal Claims recently denied the United States’ motion to dismiss a patent infringement suit related to production of a COVID-19 vaccine. The court held that it had jurisdiction because the plaintiff filed its claim there before it filed a parallel suit in a district court and because it adequately pleaded the government’s involvement.

...

Read More

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.